FindTrial
Sign In

Interferon gamma

DRUG9 trials

Sponsors

Assistance Publique Hopitaux De Paris, National Institute of Allergy and Infectious Diseases (NIAID), FDA Office of Orphan Products Development, M.D. Anderson Cancer Center, SPP Pharmaclon Ltd.

Conditions

COVID-19 Respiratory InfectionFallopian Tube CancerHealthyLeukocyte Adhesion Deficiency SyndromeMycobacterium Infections, AtypicalOncologyOsteopetrosisOvarian Cancer

Phase 2

Interferon Gamma for Drug Resistant Tuberculosis
CompletedNCT00001407
National Institute of Allergy and Infectious Diseases (NIAID)Pneumonia, Pulmonary Tuberculosis
Start: 1994-05-31End: 2003-05-31Target: 30Updated: 2008-03-04
Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
CompletedNCT00001905
National Institute of Allergy and Infectious Diseases (NIAID)Leukocyte Adhesion Deficiency Syndrome
Start: 1999-04-30End: 2002-03-31Target: 5Updated: 2008-03-04
Treatment of Non-Tuberculous Mycobacterial Infections With Interferon Gamma
CompletedNCT00001318
National Institute of Allergy and Infectious Diseases (NIAID)Healthy, Mycobacterium Infections, Atypical
Start: 1992-08-31End: 2000-11-30Target: 60Updated: 2008-03-04
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
CompletedNCT00501644
M.D. Anderson Cancer CenterFallopian Tube Cancer, Ovarian Cancer, Peritoneal Cancer
Start: 2003-01-31End: 2009-01-31Updated: 2012-08-07
PALETTE - Adaptive platform trial for personalisation of sepsis treatment in children and adults: a multi-national, treatable traits-guided, adaptive, exploratory, bayesian basket trial
Not yet recruitingCTIS2025-521371-31-00
Assistance Publique Hopitaux De ParisSepsis
Target: 2000Updated: 2025-11-24

Phase 3

Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis
CompletedNCT00004402
FDA Office of Orphan Products DevelopmentOsteopetrosis
Start: 1999-11-30End: 2000-06-30Target: 30Updated: 2015-03-25
Human Recombinant Interferon Gamma in the Treatment of Ventilator-acquired Pneumonia in ICU Patients
RecruitingNCT05843786
Hospices Civils de LyonPneumonia, Ventilator-Associated
Start: 2023-06-30End: 2027-07-30Target: 132Updated: 2025-11-21

Unknown Phase

Study of the Use of the Drug Ingaron in Patients With COVID-19
CompletedNCT05386459
SPP Pharmaclon Ltd.COVID-19 Respiratory Infection, Viral Pneumonia
Start: 2020-04-21End: 2020-10-01Updated: 2022-05-27
The 1st Tumor CytokinoTherapy Database (TCTD-1)
RecruitingNCT06222801
OncoCareClinic 308 LtdOncology
Start: 2022-09-19End: 2032-12-01Target: 5000Updated: 2024-06-10

Related Papers

Three-month outcomes and cost-effectiveness of interferon gamma-1b in critically ill patients: a secondary analysis of the PREV-HAP trial.
2024-10-11